Aisling Capital Iv, Lp Insider Trades

Insider Trading History

Track insider trading activity for Aisling Capital Iv, Lp. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Elevation Oncology
Elevation Oncology ELEV
10% owner
Holding Value $11.4k 31,238 shares
Last Trade
Jun 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.9k 31,238 shares
$1.47
$0.36
Elevation Oncology
Elevation Oncology ELEV
10% owner
Holding Value $5.7k 15,619 shares
Last Trade
Jun 17, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 15,619 shares
$1.31
$0.36
Elevation Oncology
Elevation Oncology ELEV
10% owner
Holding Value $1.03M 2,834,910 shares
Last Trade
Jun 29, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.39M 187,500 shares
$12.74
$0.36
Elevation Oncology
Elevation Oncology ELEV
10% owner
Holding Value $11.4k 31,238 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.36
Zosano Pharma
Zosano Pharma ZSAN
10% owner
Holding Value $1.52M 2,718,226 shares
Last Trade
Dec 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.2M 689,655 shares
$62.65
$0.56
Viracta Therapeutics
Viracta Therapeutics VIRX
10% owner
Holding Value $99k 10,100,000 shares
Last Trade
Jul 15, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.01
Zosano Pharma
Zosano Pharma ZSAN
10% owner
Holding Value $1.13M 2,028,571 shares
Last Trade
Apr 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.2M 428,571 shares
$121.80
$0.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up